Ferozsons Laboratories Limited (PSX:FEROZ)
330.35
+11.78 (3.70%)
At close: Sep 17, 2026
Ferozsons Laboratories Market Cap
Ferozsons Laboratories has a market cap or net worth of 14.36 billion as of September 17, 2026. Its market cap has decreased by -19.41% in one year.
Market Cap
14.36B
Enterprise Value
19.73B
Revenue
22.68B
Ranking
n/a
PE Ratio
15.25
Stock Price
330.35
ChartMarket Cap Chart
Since March 8, 1996, Ferozsons Laboratories's market cap has increased from 91.88M to 14.36B, an increase of 15,529.29%. That is a compound annual growth rate of 17.98%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 17, 2026 | 14.36B | -12.08% |
| Dec 31, 2025 | 16.33B | 12.04% |
| Dec 31, 2024 | 14.58B | 51.99% |
| Dec 29, 2023 | 9.59B | 60.41% |
| Dec 30, 2022 | 5.98B | -49.34% |
| Dec 31, 2021 | 11.80B | -1.38% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| GlaxoSmithKline Pakistan | 99.15B |
| Abbott Laboratories (Pakistan) | 89.20B |
| Highnoon Laboratories | 48.22B |
| The Searle Company | 45.28B |
| AGP Limited | 41.85B |
| Citi Pharma | 16.36B |
| Macter International | 10.93B |
| Otsuka Pakistan | 4.11B |